NAV
14.74(-2.40%)Fund Size (CR)
₹221.78Expense Ratio
2.35Scheme Type
Active FundValue Research
-
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹500Minimum Withdrawal
₹1,000Exit Load
0.5%Return Since Launch
9.91%
Basic Details
Scheme Manager
Rohan Korde
Bench Mark
NIFTY Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | March 11, 2026 | 9749.91 | -2.50% | - | -0.64% | 945/995 |
| 1 Month | February 18, 2026 | 9860.83 | -1.39% | - | -6.40% | 43/986 |
| 3 Month | December 18, 2025 | 9670.17 | -3.30% | - | -5.17% | 305/960 |
| 6 Month | September 18, 2025 | 9153.86 | -8.46% | - | -6.43% | 592/916 |
| 1 Year | March 18, 2025 | 9921.02 | -0.79% | -0.79% | 8.66% | 765/860 |
| 3 Year | March 17, 2023 | 17215.11 | 72.15% | 19.81% | 18.48% | 191/518 |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | November 8, 2021 | 15099.20 | 50.99% | 9.91% | 8.62% | 590/999 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | April 1, 2025 | 1,20,000 | 111644.47 | -6.96% | -6.96% |
| 3 Year | April 3, 2023 | 3,60,000 | 389760.25 | 8.27% | 2.68% |
| 5 Year | December 1, 2021 | 5,20,000 | 641792.17 | 23.42% | 4.30% |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.51%
Standard Deviation
0.91%
Beta
0.82%
Sharpe Ratio
-0.05%
Treynor's Ratio
-2.27%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 11.12% | 141945 | 24.66 | Equity | Pharmaceuticals |
| Divi's Lab. | 9.01% | 31171 | 19.98 | Equity | Pharmaceuticals |
| Apollo Hospitals | 6.62% | 18784 | 14.69 | Equity | Healthcare |
| Max Healthcare | 5.94% | 120721 | 13.18 | Equity | Healthcare |
| Torrent Pharma. | 5.17% | 26446 | 11.46 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 4.45% | 80858 | 9.87 | Equity | Pharmaceuticals |
| Fortis Health. | 3.85% | 90524 | 8.53 | Equity | Healthcare |
| Lupin | 3.74% | 36050 | 8.30 | Equity | Pharmaceuticals |
| Alkem Lab | 3.17% | 12453 | 7.02 | Equity | Pharmaceuticals |
| Aster DM Health. | 3.16% | 107134 | 7.01 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct (G) | 519.50 | 19.60% | 48.93% | 52.08% | 132.31% | 50.43% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 519.50 | 19.60% | 48.93% | 52.08% | 132.31% | 50.43% | |
| HDFC Defence Fund - Direct (G) | 8096.66 | -1.72% | 8.76% | -2.40% | 36.88% | - | |
| HDFC Defence Fund - Direct (IDCW) | 8096.66 | -1.72% | 8.76% | -2.40% | 36.88% | - | |
| Franklin Asian Equity Fund - Direct (G) | 426.90 | -1.72% | 10.79% | 14.01% | 33.42% | 16.69% |
List of Schemes under ITI Mutual Fund
News
ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its schemes
ITI Mutual Fund has announced 03 February 2026 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following scheme. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:ITI Balanced Advantage Fund:
Regular Plan ' IDCW: 0.12
Direct Plan ' IDCW: 0.12
ITI Consumption Fund:
Regular Plan ' IDCW: 0.60
Direct Plan ' IDCW: 0.60
ITI Banking and Financial Services Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
ITI Flexi Cap Fund:
Regular Plan ' IDCW: 0.60
Direct Plan ' IDCW: 0.60
ITI Focused Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
ITI Large Cap Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
ITI ELSS Tax Saver Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
ITI Multi Cap Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
ITI Mid Cap Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
ITI Small Cap Fund:
Regular Plan ' IDCW: 0.60
Direct Plan ' IDCW: 0.60
ITI Value Fund:
Regular Plan ' IDCW: 1.00
Direct Plan ' IDCW: 1.00
Powered by Capital Market - Live News
ITI Mutual Fund announces change in Key Personnel
ITI Mutual Fund has announced the Mr. Chetan Shah (DIN: 08038633) has been appointed, as an Independent Director of ITI Asset Management Limited (ITIAML) with effect from December 12, 2025.Details of Mr. Chetan Shah
Age: 62 years
Designation: Independent Director
Qualification: MBA in Marketing of Financial Services (University of Paisley)
Powered by Capital Market - Live News
ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme
ITI Mutual Fund has announced 05 December 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following scheme. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:ITI Balanced Advantage Fund:
Regular Plan ' IDCW: 0.10
Direct Plan ' IDCW: 0.10
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
October 18, 2021
Total AUM (Cr)
₹221.78
ITI Pharma and Healthcare Fund (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, ITI Mutual Fund. Launched in October 18, 2021, this fund is managed by Rohan Korde. With assets under management (AUM) worth ₹221.78 (Cr), as of March 19, 2026, ITI Pharma and Healthcare Fund (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 9.91% since its launch.
The current NAV of ITI Pharma and Healthcare Fund (IDCW) is ₹14.74, as on March 19, 2026. The fund's benchmark index is NIFTY Healthcare TRI. You can invest in ITI Pharma and Healthcare Fund (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 19.81% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.22% in Equity, 1.05% in Debt and 0.73% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 70.23% in Pharmaceuticals & Biotech, 22.29% in Healthcare Services, 1.76% in Cash & Others, 1.41% in Insurance, 1.31% in Fertilisers & Agrochemica
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors